nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.284	1	CrCtD
Medroxyprogesterone Acetate—breast cancer—Dexamethasone—ankylosing spondylitis	0.121	0.5	CpDpCtD
Medroxyprogesterone Acetate—breast cancer—Betamethasone—ankylosing spondylitis	0.121	0.5	CpDpCtD
Medroxyprogesterone Acetate—PGR—Betamethasone—ankylosing spondylitis	0.0343	0.186	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Methylprednisolone—ankylosing spondylitis	0.0269	0.146	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Triamcinolone—ankylosing spondylitis	0.0204	0.111	CbGbCtD
Medroxyprogesterone Acetate—PGR—Dexamethasone—ankylosing spondylitis	0.0199	0.108	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Betamethasone—ankylosing spondylitis	0.0175	0.0952	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisolone—ankylosing spondylitis	0.0173	0.0939	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisone—ankylosing spondylitis	0.0163	0.0887	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Dexamethasone—ankylosing spondylitis	0.0102	0.0554	CbGbCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisone—ankylosing spondylitis	0.00724	0.0292	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisolone—ankylosing spondylitis	0.00706	0.0285	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Methylprednisolone—ankylosing spondylitis	0.0067	0.027	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Methylprednisolone—ankylosing spondylitis	0.00623	0.0251	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Betamethasone—ankylosing spondylitis	0.00613	0.0247	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Dexamethasone—ankylosing spondylitis	0.00613	0.0247	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Prednisolone—ankylosing spondylitis	0.00596	0.0241	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Methylprednisolone—ankylosing spondylitis	0.00582	0.0235	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.00564	0.0228	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Prednisolone—ankylosing spondylitis	0.00555	0.0224	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Methylprednisolone—ankylosing spondylitis	0.00548	0.0221	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Betamethasone—ankylosing spondylitis	0.00539	0.0217	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Dexamethasone—ankylosing spondylitis	0.00539	0.0217	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisone—ankylosing spondylitis	0.00532	0.0214	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Triamcinolone—ankylosing spondylitis	0.00527	0.0212	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisolone—ankylosing spondylitis	0.00519	0.0209	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisone—ankylosing spondylitis	0.00515	0.0208	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.00503	0.0203	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisone—ankylosing spondylitis	0.005	0.0202	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.00495	0.02	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.00495	0.02	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Methylprednisolone—ankylosing spondylitis	0.0049	0.0198	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisolone—ankylosing spondylitis	0.00488	0.0197	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.00484	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Betamethasone—ankylosing spondylitis	0.00483	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Dexamethasone—ankylosing spondylitis	0.00483	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Triamcinolone—ankylosing spondylitis	0.00472	0.019	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Methylprednisolone—ankylosing spondylitis	0.00455	0.0184	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.00448	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Betamethasone—ankylosing spondylitis	0.00448	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Dexamethasone—ankylosing spondylitis	0.00448	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisone—ankylosing spondylitis	0.00448	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Triamcinolone—ankylosing spondylitis	0.00438	0.0177	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisolone—ankylosing spondylitis	0.00437	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Prednisolone—ankylosing spondylitis	0.00437	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisone—ankylosing spondylitis	0.00436	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.00426	0.0172	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Betamethasone—ankylosing spondylitis	0.00419	0.0169	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Dexamethasone—ankylosing spondylitis	0.00419	0.0169	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisone—ankylosing spondylitis	0.00416	0.0168	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Triamcinolone—ankylosing spondylitis	0.00409	0.0165	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisolone—ankylosing spondylitis	0.00406	0.0164	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.004	0.0161	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.00394	0.0159	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.00394	0.0159	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisone—ankylosing spondylitis	0.00388	0.0157	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.00385	0.0155	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisolone—ankylosing spondylitis	0.00379	0.0153	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Prednisolone—ankylosing spondylitis	0.00379	0.0153	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00376	0.0204	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisone—ankylosing spondylitis	0.00365	0.0147	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.00356	0.0144	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0035	0.019	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00285	0.0155	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00244	0.0133	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Betamethasone—ankylosing spondylitis	0.00244	0.0133	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisolone—ankylosing spondylitis	0.00241	0.0131	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisone—ankylosing spondylitis	0.00228	0.0124	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00142	0.00773	CbGbCtD
Medroxyprogesterone Acetate—Vertigo—Betamethasone—ankylosing spondylitis	3.03e-05	0.000711	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	3.02e-05	0.00071	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Betamethasone—ankylosing spondylitis	3.02e-05	0.000709	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Dexamethasone—ankylosing spondylitis	3.02e-05	0.000709	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Triamcinolone—ankylosing spondylitis	3.01e-05	0.000707	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Methotrexate—ankylosing spondylitis	3.01e-05	0.000706	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methylprednisolone—ankylosing spondylitis	3e-05	0.000705	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Triamcinolone—ankylosing spondylitis	2.98e-05	0.0007	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisolone—ankylosing spondylitis	2.98e-05	0.0007	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Prednisone—ankylosing spondylitis	2.98e-05	0.000699	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Methylprednisolone—ankylosing spondylitis	2.97e-05	0.000698	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	2.97e-05	0.000697	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	2.97e-05	0.000696	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Betamethasone—ankylosing spondylitis	2.96e-05	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	2.96e-05	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Methotrexate—ankylosing spondylitis	2.96e-05	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisolone—ankylosing spondylitis	2.96e-05	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Triamcinolone—ankylosing spondylitis	2.96e-05	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Prednisone—ankylosing spondylitis	2.95e-05	0.000693	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Methylprednisolone—ankylosing spondylitis	2.95e-05	0.000693	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methylprednisolone—ankylosing spondylitis	2.94e-05	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Prednisone—ankylosing spondylitis	2.93e-05	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Prednisone—ankylosing spondylitis	2.93e-05	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	2.93e-05	0.000688	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	2.92e-05	0.000686	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Dexamethasone—ankylosing spondylitis	2.92e-05	0.000685	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Betamethasone—ankylosing spondylitis	2.92e-05	0.000685	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Betamethasone—ankylosing spondylitis	2.87e-05	0.000673	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Dexamethasone—ankylosing spondylitis	2.87e-05	0.000673	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Betamethasone—ankylosing spondylitis	2.86e-05	0.000671	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Dexamethasone—ankylosing spondylitis	2.86e-05	0.000671	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Dexamethasone—ankylosing spondylitis	2.83e-05	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Betamethasone—ankylosing spondylitis	2.83e-05	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Methotrexate—ankylosing spondylitis	2.83e-05	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methylprednisolone—ankylosing spondylitis	2.83e-05	0.000663	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Methotrexate—ankylosing spondylitis	2.82e-05	0.000661	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Methotrexate—ankylosing spondylitis	2.82e-05	0.000661	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Methotrexate—ankylosing spondylitis	2.8e-05	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	2.78e-05	0.000653	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—ankylosing spondylitis	2.76e-05	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	2.76e-05	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	2.75e-05	0.000647	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Dexamethasone—ankylosing spondylitis	2.75e-05	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Betamethasone—ankylosing spondylitis	2.75e-05	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	2.75e-05	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	2.75e-05	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Triamcinolone—ankylosing spondylitis	2.74e-05	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methylprednisolone—ankylosing spondylitis	2.73e-05	0.000642	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Dexamethasone—ankylosing spondylitis	2.73e-05	0.000641	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Betamethasone—ankylosing spondylitis	2.73e-05	0.000641	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisone—ankylosing spondylitis	2.72e-05	0.000639	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Triamcinolone—ankylosing spondylitis	2.72e-05	0.000639	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisolone—ankylosing spondylitis	2.72e-05	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	2.72e-05	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—ankylosing spondylitis	2.71e-05	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Prednisone—ankylosing spondylitis	2.71e-05	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Dexamethasone—ankylosing spondylitis	2.71e-05	0.000635	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Betamethasone—ankylosing spondylitis	2.71e-05	0.000635	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Triamcinolone—ankylosing spondylitis	2.7e-05	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	2.7e-05	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Betamethasone—ankylosing spondylitis	2.7e-05	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Prednisone—ankylosing spondylitis	2.7e-05	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	2.69e-05	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	2.69e-05	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Dexamethasone—ankylosing spondylitis	2.68e-05	0.00063	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Betamethasone—ankylosing spondylitis	2.68e-05	0.00063	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisone—ankylosing spondylitis	2.68e-05	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Triamcinolone—ankylosing spondylitis	2.67e-05	0.000626	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—ankylosing spondylitis	2.66e-05	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	2.66e-05	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	2.66e-05	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	2.66e-05	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Prednisone—ankylosing spondylitis	2.65e-05	0.000621	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Prednisone—ankylosing spondylitis	2.64e-05	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—ankylosing spondylitis	2.63e-05	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Prednisone—ankylosing spondylitis	2.63e-05	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—ankylosing spondylitis	2.63e-05	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Betamethasone—ankylosing spondylitis	2.62e-05	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Dexamethasone—ankylosing spondylitis	2.62e-05	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisolone—ankylosing spondylitis	2.62e-05	0.000614	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—ankylosing spondylitis	2.61e-05	0.000614	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Triamcinolone—ankylosing spondylitis	2.61e-05	0.000613	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methylprednisolone—ankylosing spondylitis	2.61e-05	0.000612	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisone—ankylosing spondylitis	2.58e-05	0.000605	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Dexamethasone—ankylosing spondylitis	2.57e-05	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Betamethasone—ankylosing spondylitis	2.57e-05	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—ankylosing spondylitis	2.56e-05	0.0006	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—ankylosing spondylitis	2.54e-05	0.000597	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Prednisone—ankylosing spondylitis	2.54e-05	0.000597	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	2.54e-05	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—ankylosing spondylitis	2.53e-05	0.000593	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	2.51e-05	0.000588	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	2.51e-05	0.000588	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Prednisone—ankylosing spondylitis	2.5e-05	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Prednisone—ankylosing spondylitis	2.5e-05	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	2.5e-05	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	2.49e-05	0.000585	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Prednisone—ankylosing spondylitis	2.49e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—ankylosing spondylitis	2.49e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Dexamethasone—ankylosing spondylitis	2.49e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Betamethasone—ankylosing spondylitis	2.49e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	2.48e-05	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	2.47e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Betamethasone—ankylosing spondylitis	2.47e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Dexamethasone—ankylosing spondylitis	2.47e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Prednisone—ankylosing spondylitis	2.47e-05	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—ankylosing spondylitis	2.47e-05	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Methotrexate—ankylosing spondylitis	2.45e-05	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—ankylosing spondylitis	2.45e-05	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisolone—ankylosing spondylitis	2.43e-05	0.00057	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Betamethasone—ankylosing spondylitis	2.42e-05	0.000568	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Dexamethasone—ankylosing spondylitis	2.42e-05	0.000568	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Triamcinolone—ankylosing spondylitis	2.41e-05	0.000565	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methylprednisolone—ankylosing spondylitis	2.4e-05	0.000564	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—ankylosing spondylitis	2.4e-05	0.000564	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Triamcinolone—ankylosing spondylitis	2.4e-05	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisone—ankylosing spondylitis	2.39e-05	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Prednisone—ankylosing spondylitis	2.39e-05	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	2.39e-05	0.000561	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Dexamethasone—ankylosing spondylitis	2.39e-05	0.000561	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Betamethasone—ankylosing spondylitis	2.39e-05	0.000561	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Prednisone—ankylosing spondylitis	2.38e-05	0.000558	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	2.37e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	2.37e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—ankylosing spondylitis	2.37e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dexamethasone—ankylosing spondylitis	2.37e-05	0.000556	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Betamethasone—ankylosing spondylitis	2.37e-05	0.000556	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Prednisone—ankylosing spondylitis	2.36e-05	0.000553	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Prednisone—ankylosing spondylitis	2.35e-05	0.000551	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Prednisone—ankylosing spondylitis	2.34e-05	0.000549	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Prednisone—ankylosing spondylitis	2.33e-05	0.000546	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisone—ankylosing spondylitis	2.32e-05	0.000543	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Prednisone—ankylosing spondylitis	2.28e-05	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	2.28e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—ankylosing spondylitis	2.27e-05	0.000532	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Betamethasone—ankylosing spondylitis	2.27e-05	0.000532	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	2.27e-05	0.000532	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	2.25e-05	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	2.25e-05	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.23e-05	0.000524	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.23e-05	0.000523	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—ankylosing spondylitis	2.21e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—ankylosing spondylitis	2.2e-05	0.000517	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Dexamethasone—ankylosing spondylitis	2.18e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Betamethasone—ankylosing spondylitis	2.18e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	2.18e-05	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisolone—ankylosing spondylitis	2.18e-05	0.000511	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Triamcinolone—ankylosing spondylitis	2.17e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Betamethasone—ankylosing spondylitis	2.17e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dexamethasone—ankylosing spondylitis	2.17e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dexamethasone—ankylosing spondylitis	2.17e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Betamethasone—ankylosing spondylitis	2.17e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methylprednisolone—ankylosing spondylitis	2.17e-05	0.000509	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisone—ankylosing spondylitis	2.17e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisone—ankylosing spondylitis	2.15e-05	0.000505	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Triamcinolone—ankylosing spondylitis	2.14e-05	0.000503	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methylprednisolone—ankylosing spondylitis	2.14e-05	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—ankylosing spondylitis	2.12e-05	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Prednisone—ankylosing spondylitis	2.11e-05	0.000495	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—ankylosing spondylitis	2.09e-05	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—ankylosing spondylitis	2.09e-05	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—ankylosing spondylitis	2.09e-05	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Prednisone—ankylosing spondylitis	2.08e-05	0.000489	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisolone—ankylosing spondylitis	2.08e-05	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisolone—ankylosing spondylitis	2.08e-05	0.000487	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.07e-05	0.000487	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.07e-05	0.000486	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Prednisone—ankylosing spondylitis	2.06e-05	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisolone—ankylosing spondylitis	2.06e-05	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—ankylosing spondylitis	2.06e-05	0.000484	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Prednisone—ankylosing spondylitis	2.05e-05	0.000481	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—ankylosing spondylitis	2.02e-05	0.000474	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Triamcinolone—ankylosing spondylitis	2e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	2e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methylprednisolone—ankylosing spondylitis	2e-05	0.000469	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methotrexate—ankylosing spondylitis	1.99e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisone—ankylosing spondylitis	1.97e-05	0.000463	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Betamethasone—ankylosing spondylitis	1.97e-05	0.000463	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dexamethasone—ankylosing spondylitis	1.97e-05	0.000463	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—ankylosing spondylitis	1.96e-05	0.000461	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	1.96e-05	0.00046	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	1.96e-05	0.00046	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisolone—ankylosing spondylitis	1.96e-05	0.000459	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Betamethasone—ankylosing spondylitis	1.95e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Dexamethasone—ankylosing spondylitis	1.95e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—ankylosing spondylitis	1.94e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	1.93e-05	0.000454	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Triamcinolone—ankylosing spondylitis	1.93e-05	0.000452	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methylprednisolone—ankylosing spondylitis	1.92e-05	0.000451	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Triamcinolone—ankylosing spondylitis	1.91e-05	0.000449	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Triamcinolone—ankylosing spondylitis	1.91e-05	0.000448	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—ankylosing spondylitis	1.91e-05	0.000448	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methylprednisolone—ankylosing spondylitis	1.91e-05	0.000448	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methylprednisolone—ankylosing spondylitis	1.9e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisone—ankylosing spondylitis	1.9e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Triamcinolone—ankylosing spondylitis	1.9e-05	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methylprednisolone—ankylosing spondylitis	1.89e-05	0.000445	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Prednisone—ankylosing spondylitis	1.89e-05	0.000444	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Prednisone—ankylosing spondylitis	1.89e-05	0.000444	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dexamethasone—ankylosing spondylitis	1.88e-05	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Betamethasone—ankylosing spondylitis	1.88e-05	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—ankylosing spondylitis	1.87e-05	0.000439	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	1.82e-05	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Dexamethasone—ankylosing spondylitis	1.82e-05	0.000427	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Betamethasone—ankylosing spondylitis	1.82e-05	0.000427	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—ankylosing spondylitis	1.81e-05	0.000425	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Triamcinolone—ankylosing spondylitis	1.8e-05	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—ankylosing spondylitis	1.8e-05	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methylprednisolone—ankylosing spondylitis	1.8e-05	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—ankylosing spondylitis	1.78e-05	0.000419	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—ankylosing spondylitis	1.78e-05	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisone—ankylosing spondylitis	1.76e-05	0.000414	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—ankylosing spondylitis	1.76e-05	0.000413	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dexamethasone—ankylosing spondylitis	1.75e-05	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Betamethasone—ankylosing spondylitis	1.75e-05	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—ankylosing spondylitis	1.74e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Betamethasone—ankylosing spondylitis	1.73e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dexamethasone—ankylosing spondylitis	1.73e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Dexamethasone—ankylosing spondylitis	1.73e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Betamethasone—ankylosing spondylitis	1.73e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	1.73e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—ankylosing spondylitis	1.73e-05	0.000405	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Dexamethasone—ankylosing spondylitis	1.72e-05	0.000404	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Betamethasone—ankylosing spondylitis	1.72e-05	0.000404	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Prednisone—ankylosing spondylitis	1.72e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Prednisone—ankylosing spondylitis	1.69e-05	0.000398	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—ankylosing spondylitis	1.65e-05	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Prednisone—ankylosing spondylitis	1.64e-05	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	1.64e-05	0.000384	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dexamethasone—ankylosing spondylitis	1.63e-05	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Betamethasone—ankylosing spondylitis	1.63e-05	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—ankylosing spondylitis	1.59e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisone—ankylosing spondylitis	1.58e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—ankylosing spondylitis	1.58e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—ankylosing spondylitis	1.58e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Prednisone—ankylosing spondylitis	1.52e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisone—ankylosing spondylitis	1.51e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisone—ankylosing spondylitis	1.51e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisone—ankylosing spondylitis	1.5e-05	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.47e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—ankylosing spondylitis	1.44e-05	0.000337	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisone—ankylosing spondylitis	1.42e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—ankylosing spondylitis	1.42e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—ankylosing spondylitis	1.37e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—ankylosing spondylitis	1.32e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—ankylosing spondylitis	1.27e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methotrexate—ankylosing spondylitis	1.26e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—ankylosing spondylitis	1.26e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methotrexate—ankylosing spondylitis	1.25e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methotrexate—ankylosing spondylitis	1.19e-05	0.000279	CcSEcCtD
